Literature DB >> 21595747

The clinical benefit of evaluating health-related quality-of-life in children with problematic severe asthma.

B Nordlund1, J R Konradsen, C Pedroletti, I Kull, G Hedlin.   

Abstract

AIM: To evaluate health-related quality-of-life (HR-QoL) and the asthma control test (ACT) in children with problematic severe asthma and those with controlled asthma and to identify whether clinical characteristics show correlations with these measurements.
METHODS: This multicentre cross-sectional study included 93 children in total, 54 with problematic severe asthma and 39 age-matched with controlled asthma. Subjects completed the Paediatric Asthma Quality-of-Life Questionnaire as well as a standardized health questionnaire and the ACT. Objective measurements of exhaled nitric oxide, specific sensitization, pulmonary function and bronchial hyper-responsiveness to methacholine were also taken.
RESULTS: HR-QoL was reduced in children with problematic severe asthma (5.4 vs. 6.7, p < 0.001), particularly for girls (5.1 vs. 5.6 for boys, p = 0.02), and their ACT scores were also lower (17 vs. 23, p < 0.001) compared with those of subjects with controlled asthma. A HR-QoL score <6.2 discriminated problematic severe asthma from controlled asthma with 85% sensitivity and 97% specificity, as did the ACT score <20 (79% sensitivity and 94% specificity). Objective measures and other clinical characteristics were weakly associated with HR-QoL or ACT score.
CONCLUSION: Subjective measurements of HR-QoL and asthma control are both equally useful in differentiating children with problematic severe asthma from those with controlled asthma.
© 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica.

Entities:  

Mesh:

Year:  2011        PMID: 21595747     DOI: 10.1111/j.1651-2227.2011.02359.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Quality of life in children with asthma in Rio de Janeiro, Brazil.

Authors:  Patricia Gomes de Souza; Clemax Couto Sant'anna; Maria de Fátima B Pombo March
Journal:  Indian J Pediatr       Date:  2012-12-21       Impact factor: 1.967

Review 2.  Pediatric severe asthma: a case series report and perspectives on anti-IgE treatment.

Authors:  Virginia Mirra; Silvia Montella; Francesca Santamaria
Journal:  BMC Pediatr       Date:  2018-02-21       Impact factor: 2.125

3.  QUALITY OF LIFE EVALUATION AND ASSOCIATED FACTORSIN ASTHMATIC CHILDREN AND ADOLESCENTS ATTENDED IN A SPECIALIZED OUTPATIENT CLINIC.

Authors:  Fernanda Chedid de Souza Fontan; Sérgio Wilson Duwe; Karoliny Dos Santos; Jane da Silva
Journal:  Rev Paul Pediatr       Date:  2020-01-13

4.  Heart rate variability reflects the natural history of physiological development in healthy children and is not associated with quality of life.

Authors:  Georg Seifert; Gabriele Calaminus; Andreas Wiener; Dirk Cysarz
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

5.  Severe asthma features in children: a case-control online survey.

Authors:  Silvia Montella; Eugenio Baraldi; Salvatore Cazzato; Raffaele Aralla; Mariangela Berardi; Luigia Maria Brunetti; Fabio Cardinale; Renato Cutrera; Fernando Maria de Benedictis; Emanuela di Palmo; Sabrina Di Pillo; Grazia Fenu; Stefania La Grutta; Enrico Lombardi; Giorgio Piacentini; Francesca Santamaria; Nicola Ullmann; Franca Rusconi
Journal:  Ital J Pediatr       Date:  2016-01-22       Impact factor: 2.638

6.  Associations between lower urinary tract dysfunction and health-related quality of life in children with chronic kidney disease.

Authors:  Helena Öborn; Lena Wettergren; Maria Herthelius; Ulla Forinder
Journal:  Acta Paediatr       Date:  2016-05-27       Impact factor: 2.299

7.  Assessment of Quality of Life of Primary Caregivers of Egyptian Asthmatic Children and Adolescents.

Authors:  Hala G Elnady; Lobna S Sherif; Hala D ElGindi; Fatma A Shaaban; Aida M Abdelmohsen; Dina A Salah; Ghada A Abdel-Latif; Reham F Fahmy
Journal:  Indian J Community Med       Date:  2020-10-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.